...
首页> 外文期刊>癌と化学療法 >Complete response in a case of advanced esophageal cancer treated by combined chemotherapy of TS-1 and CDDP with radiotherapy
【24h】

Complete response in a case of advanced esophageal cancer treated by combined chemotherapy of TS-1 and CDDP with radiotherapy

机译:TS-1和CDDP联合放疗联合化疗治疗晚期食管癌完全缓解

获取原文
获取原文并翻译 | 示例
           

摘要

A 70-year-old patient with advanced esophageal cancer with invasion to the aorta was treated by combined chemotherapy of TS-1 and CDDP with radiotherapy. TS-1 (80 mg/m2) was administered for 14 days followed by 14 days rest, CDDP (70 mg/m2) was administered by 24 h continuous intravenous infusion at day 8 after the start of TS-1. Radiotherapy (5 days/week) at 2 Gy/day was concurrently started from the beginning of chemotherapy for 3 weeks. After the end of the first course, leukocytopenia of grade 2 and thrombocytopenia of grade 2 were observed. The second course of chemoradiotherapy was suspended for 1 week. After recovery from the toxicity, the second course was started. After the 2 courses of chemoradiotherapy, endoscopic examination with biopsy revealed the disappearance of the esophageal cancer. Combined chemotherapy of TS-1 and CDDP was administered 2 times after chemoradiotherapy. After this therapy, endoscopy and a CT showed a complete clinical response. No severe adverse effects were observed during this therapy. Combined chemotherapy of TS-1 and CDDP with radiotherapy can be effective for advanced esophageal cancer.
机译:将TS-1和CDDP联合放疗联合化疗,治疗一名70岁晚期食管癌并侵犯主动脉的患者。 TS-1(80 mg / m2)给药14天,然后休息14天,在TS-1开始后第8天连续24 h静脉输注CDDP(70 mg / m2)。从化疗开始开始同时进行2 Gy /天的放疗(5天/周),持续3周。在第一个疗程结束后,观察到2级白细胞减少和2级血小板减少。第二疗程放疗暂停了1周。从毒性中恢复后,开始第二个疗程。经过2个疗程的放化疗后,经活检内窥镜检查发现食管癌消失。放化疗后2次联合给予TS-1和CDDP联合化疗。进行这种治疗后,内窥镜检查和CT显示完全的临床反应。在该疗法中未观察到严重的不良反应。 TS-1和CDDP联合放疗联合化疗可有效治疗晚期食管癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号